NASDAQ:TTRX
Turn Therapeutics Inc.
Turn Therapeutics Inc. reported net income of −$3.2M in fiscal 2025. The diluted share count rose 4.0%.Summary generated from Turn Therapeutics Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−141.7%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+4.0%
Financials
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | n/a | n/a |
| Operating income | −2 | −6 |
| Net income | −2 | −3 |
| Free cash flow | n/a | n/a |
Recent filings
- 8-KRegulation FD disclosure
Oct 7, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 8-KRegulation FD disclosure
Sep 9, 2026 - 8-KCurrent report
Aug 18, 2026 - 8-KRegulation FD disclosure
Aug 17, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 12, 2026 - 8-KResults of operations and financial condition
Aug 12, 2026 - 8-KRegulation FD disclosure
Jul 28, 2026